Go Deep
BioVie Inc.
BioVie Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,024 | -0.4 | 0.95 | 0.03 | 107.03 |
| Oct 2026 | 21,902 | -0.4 | 1.01 | 0.03 | 113.66 |
| Oct 2026 | 21,606 | -0.4 | 1.16 | 0.03 | 129.90 |
| Oct 2026 | 21,832 | -0.4 | 1.05 | 0.03 | 117.57 |
| Oct 2026 | 21,797 | -0.4 | 1.06 | 0.03 | 119.17 |
| Oct 2026 | 21,763 | -0.4 | 1.08 | 0.03 | 120.82 |
BioVie Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -5,645,532.0 | -5,270,299.0 | -6,069,475.0 | -5,087,557.0 |
| EPS | — | -0.7 | -0.8 | -1.0 |
BioVie Inc. Revenue & Profit: Last 5 Years
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Profit | -22,072,863.0 | -17,542,120.0 | -32,120,533.0 | -50,255,815.0 | — |
| EPS | — | -12.1 | -73.0 | -154.7 | -106.0 |
BioVie Inc. Balance Sheet
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Total Assets | 14,250,462.0 | 21,562,199.0 | 25,208,345.0 | 35,104,730.0 | — |
| Total Liabilities | 3,980,192.0 | 2,550,214.0 | 9,702,130.0 | 19,764,444.0 | — |
| Total Equity | 10,270,270.0 | 19,011,985.0 | 15,506,215.0 | 15,340,286.0 | — |
Owes vs Owns
BioVie Inc. owed $0.28 for every $1 it owned in Jun 2026, down from $0.56 in Jun 2023.
| Period | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.28× | 0.12× | 0.38× | 0.56× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
BioVie Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Jun 2026
Cash & short-term investments 63.0%Receivables 15.1%Fixed assets (tangible) 1.8%Intangible assets 2.4%Other assets 17.6%
How it's funded — Jun 2026
Short-term debt 0.6%Long-term debt 1.3%Payables 26.0%Shareholders' equity 72.1%
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 9.0 | 17.5 | 23.8 | 33.9 |
| Receivables | 2.2 | 2.1 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.3 | 0.3 | 0.4 | 0.1 |
| Intangible assets | 0.3 | 0.5 | 0.8 | 1.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 2.5 | 1.0 | 0.2 | 0.1 |
| Liabilities & equity | ||||
| Short-term debt | 0.1 | 0.1 | 5.7 | 9.1 |
| Long-term debt | 0.2 | 0.3 | 0.3 | 5.2 |
| Payables | 3.7 | 2.2 | 3.6 | 3.5 |
| Other liabilities | 0.0 | 0.0 | 0.1 | 2.0 |
| Shareholders' equity | 10.3 | 19.0 | 15.5 | 15.3 |
| Net tangible assets | 9.9 | 18.5 | 14.8 | 14.4 |
BioVie Inc. Cash Flow
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Operating Activities | -19,024,806.0 | -19,025,205.0 | -27,945,024.0 | -40,252,881.0 | — |
| Investing Activities | — | 0.0 | 14,525,000.0 | -14,301,135.0 | 0.0 |
| Financing Activities | 10,457,629.0 | 12,725,954.0 | 17,802,939.0 | 55,373,183.0 | — |